The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors
- PMID: 7518271
- DOI: 10.1007/978-3-7091-9326-6_2
The genetic and functional basis of HIV-1 resistance to nonnucleoside reverse transcriptase inhibitors
Abstract
The nonnucleoside reverse transcriptase (RT) inhibitors are structurally diverse compounds that are specific inhibitors of the human immunodeficiency virus type 1 RT enzyme. The compounds are largely functionally identical and bind to a common site in the enzyme. HIV-1 variants that exhibit reduced susceptibility to these inhibitors have been derived in cell culture and, more recently, from HIV-1-infected patients undergoing experimental therapy. The variants express amino acid substitutions at RT positions that apparently interact directly with the inhibitors. Effects of specific substitutions at these positions vary among the compounds, suggesting subtle differences in how the compounds physically interact with the enzyme.
Similar articles
-
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitors.J Biol Chem. 1992 Sep 5;267(25):17526-30. J Biol Chem. 1992. PMID: 1381350
-
A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors.Proc Natl Acad Sci U S A. 1993 May 15;90(10):4713-7. doi: 10.1073/pnas.90.10.4713. Proc Natl Acad Sci U S A. 1993. PMID: 7685109 Free PMC article.
-
Mutational analysis of residue 190 of human immunodeficiency virus type 1 reverse transcriptase.Virology. 1994 May 1;200(2):696-701. doi: 10.1006/viro.1994.1233. Virology. 1994. PMID: 7513921
-
Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.Adv Exp Med Biol. 1996;394:291-8. doi: 10.1007/978-1-4757-9209-6_26. Adv Exp Med Biol. 1996. PMID: 8815693 Review. No abstract available.
-
[Highly specific inhibitors of human immunodeficiency virus type I that are particularly targeted at the reverse transcriptase].Pathol Biol (Paris). 1993 Mar;41(3):230-6. Pathol Biol (Paris). 1993. PMID: 7687340 Review. French. No abstract available.
Cited by
-
The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity.Proc Natl Acad Sci U S A. 1996 Feb 6;93(3):969-73. doi: 10.1073/pnas.93.3.969. Proc Natl Acad Sci U S A. 1996. PMID: 8577770 Free PMC article.
-
SRR-SB3, a disulfide-containing macrolide that inhibits a late stage of the replicative cycle of human immunodeficiency virus.Antimicrob Agents Chemother. 1997 Feb;41(2):262-8. doi: 10.1128/AAC.41.2.262. Antimicrob Agents Chemother. 1997. PMID: 9021177 Free PMC article.